## EXPD: Expeditors International of Was - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 2.3% below STRENGTH zone (3.0-6.0%); PEG 4.90 fails VALUE criteria (<1.0); RSI 72 overbought. Stock is in no-man's land without clear edge. Caution: overbought RSI (72).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($146.58)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 6
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. Expeditors International Soars to All-Time Stock High Amidst Robust Performance and Strategic Acumen**
- Source: Markets Financial Content | 20251211T161324 | Bullish | Relevance: 99%
-  Expeditors International of Washington Inc. (NASDAQ: EXPD) reached an unprecedented all-time high stock price of $151.70 USD on December 11, 2025, reflecting strong investor confidence and strategic acumen in navigating global supply chains. This performance highlights the company's asset-light model, technological investments in AI, and customer-centric approach, solidifying its position as a market leader. While facing short-term headwinds, Expeditors is poised for continued growth through e-commerce expansion, supply chain resilience solutions, and sustained investment in technology.

**2. Expeditors International of Washington's (NYSE:EXPD) Five-year Earnings Growth Trails the 12% YoY Shareholder Returns**
- Source: 富途牛牛 | 20251209T020928 | Neutral | Relevance: 98%
- This article analyzes Expeditors International of Washington's financial performance over the past five years, noting that while shareholders have seen average annual returns of 12%, the company's earnings per share (EPS) growth has been lower at 9.4% per year. This discrepancy suggests that while the business has made some progress, the share price growth has outpaced the fundamental earnings improvements. The article likely delves into factors contributing to this trend and what it means for investors.

**3. Expeditors International stock hits all-time high at 151.7 USD By Investing.com**
- Source: Investing.com South Africa | 20251211T164601 | Bullish | Relevance: 98%
-  Expeditors International of Washington Inc. (EXPD) stock reached an all-time high of $151.7 USD, reflecting significant investor confidence and robust performance for the logistics company. The stock has seen substantial gains, including 27.24% over the past year and 38.3% year-to-date, supported by a strong financial position with more cash than debt and 33 consecutive years of dividend payments. Analysts have revised earnings upwards, and recent upgrades from UBS and BofA Securities further underscore positive outlooks for the company.

**4. Expeditors International stock hits all-time high at 151.7 USD By Investing.com**
- Source: Investing.com Nigeria | 20251211T150818 | Bullish | Relevance: 98%
-  Expeditors International of Washington Inc. reached an all-time high of $151.7, marking a 27.24% increase over the past year and a 38.3% year-to-date return. The logistics company boasts a $20.3 billion market capitalization, strong financial health with more cash than debt, and a consistent 33-year dividend payment history with 29 years of increases. Analysts have revised earnings upwards, and recent news includes exceeding Q3 earnings estimates, leading to raised price targets from firms like Goldman Sachs and Stifel.

**5. Expeditors International stock hits all-time high at 151.7 USD**
- Source: Investing.com India | 20251211T151902 | Bullish | Relevance: 97%
-  Expeditors International of Washington Inc. (EXPD) stock reached an all-time high of $151.7 USD, marking significant growth over the past year. This surge reflects strong investor confidence due to robust financial performance, a market capitalization of $20.3 billion, and consistent dividend payments for 33 years. Recent analyst upgrades and strong Q3 earnings further underscore the company's positive outlook.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | Morgan Stanley | $95 | $90 | +6% |
| 2025-11-17 | UBS | $166 | $138 | +20% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | Morgan Stanley | main | Underweight |
| 2025-11-17 | UBS | up | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 2 ($0.93M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 12.5% (-0.9%)
- Blackrock Inc.: 9.2% (-10.1%)
- State Street Corpora: 5.8% (+5.1%)
- First Eagle Investme: 4.7% (+0.0%)
- LOOMIS SAYLES & CO L: 4.3% (+1.6%)

### Key Risks

1. Valuation stretched: PEG 4.9x requires aggressive growth execution.
2. Overbought RSI (72) with bearish MACD signals exhaustion.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +1.0% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 4.90 signals overvaluation risk, limited margin of safety. Forward P/E 25.7x stretched relative to 2% growth. Quality metrics strong (ROE 36%, ROA 14%). Analyst sentiment positive (2 raises, avg +13%). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $20.8B |
| Beta | 1.14 |
| 52W Range | $100.47 - $153.82 |
| Short Interest | 4.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 4.90 |
| Forward P/E | 25.7 |
| Current P/E | 26.1 |
| YoY Growth | 1.5% |
| EPS Direction | RISING |

### Technicals

MRS_10 strengthening from 1.3% to 2.3% (+1.0% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.7pp (needs >3.0% for momentum thesis). MRS_5 at 1.8% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). RSI overbought at 72, risk of mean reversion.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 2.33% (CS: 64) | Neutral |
| RSI_14 | 71.8 | Overbought |
| MACD Histogram | -0.13 | Bearish |
| vs SMA20 | 1.052x | Above |
| vs SMA50 | 1.155x | Above |
| vs SMA200 | 1.274x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $153.02
- **Stop Loss:** $146.58 (4.2% risk)
- **Target:** $159.46 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 214
- **Position Value:** $32,746.28
- **Portfolio %:** 32.75%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-24 (Est: $1.43)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.39 | $1.64 | +18.1% |
| 2025Q2 | $1.24 | $1.34 | +7.9% |
| 2025Q1 | $1.35 | $1.47 | +9.1% |
| 2024Q4 | $1.44 | $1.68 | +16.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*